Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Melbourne Health |
---|---|
Information provided by: | Melbourne Health |
ClinicalTrials.gov Identifier: | NCT00292214 |
To determine the amount of paracetamol in the blood when given in either intravenous or oral forms prior to cholecystectomy. The clinical effectiveness of each form will also be evaluated with pain scores and the use of other pain relief drugs.
Condition | Intervention | Phase |
---|---|---|
Laparoscopic Cholecystectomy |
Drug: Paracetamol (acetaminophen) |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Pharmacokinetics Study |
Official Title: | Comparative Pharmacokinetics of Intravenous and Oral Paracetamol in the Peri-Operative Period of Laparoscopic Cholecystectomy |
Estimated Enrollment: | 30 |
Study Start Date: | October 2005 |
Estimated Study Completion Date: | October 2006 |
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | 2005.138 |
Study First Received: | February 13, 2006 |
Last Updated: | March 8, 2007 |
ClinicalTrials.gov Identifier: | NCT00292214 |
Health Authority: | Australia: National Health and Medical Research Council |
paracetamol acetaminophen pharmacokinetic intravenous |
oral analgesia pain opioid |
Pain Acetaminophen |
Sensory System Agents Analgesics, Non-Narcotic Therapeutic Uses Physiological Effects of Drugs |
Peripheral Nervous System Agents Analgesics Central Nervous System Agents Pharmacologic Actions |